Phreesia, Inc. (PHR) is a publicly traded Healthcare sector company. As of September 2, 2026, PHR trades at $11.15 with a market cap of $731.85M and a P/E ratio of 74.63. PHR moved +0.08% today. Year to date, PHR is -27.30%; over the trailing twelve months it is -61.07%. Its 52-week range spans $7.77 to $32.76. Analyst consensus is buy with an average price target of $13.50. Rallies surfaces PHR's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks PHR insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.
| Metric | Value |
|---|---|
| Price | $11.15 |
| Market Cap | $731.85M |
| P/E Ratio | 74.63 |
| EPS | $0.16 |
| Dividend Yield | 0.00% |
| 52-Week High | $32.76 |
| 52-Week Low | $7.77 |
| Volume | 494.99K |
| Avg Volume | 0 |
| Revenue (TTM) | $495.59M |
| Net Income | $9.18M |
| Gross Margin | 0.00% |
5 analysts cover PHR: 0 strong buy, 2 buy, 3 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $13.50.